FDA grants Priority Review status for TLX250-CDx for kidney cancer PET/CT scans
The Food and Drug Administration (FDA) in America has accepted [...]
Kidney cancer research highlights from ASCO GU 2025
Every year, researchers from around the world gather at a [...]
New personalised cancer vaccine shows promise for advanced kidney cancer
A new personalised cancer vaccine has shown promising anti-tumour immunity [...]
Belzutifan approved in Europe for advanced kidney cancer and VHL disease
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for [...]
Belzutifan plus cabozantinib combination shows promise in advanced kidney cancer
Updated results from the phase 2 LITESPARK-003 trial with belzutifan [...]
Promising new combination therapy for advanced kidney cancer
Combinations of tyrosine kinase inhibitors plus immunotherapy have improved treatment [...]
FDA approves injectable form of nivolumab
Just after Christmas, the US Food and Drug Administration (FDA) [...]
Promising new immunotherapy combination for advanced kidney cancer
The first results from a phase 2 study (FRACTION-RCC) looking [...]
New treatment for pretreated advanced kidney cancer shows promise
A new treatment, called NDI-101150 has been shown to be [...]
First CAR T-cell therapy for kidney cancer given Advanced Therapy designation by the FDA
The US Food and Drug Administration (FDA) has granted a [...]
